Is this you? Create Your Porfile
Avatar

Bernhard Auerbach

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Bernhard Auerbach is active.

Explore More

Publication

Featured researches published by Bernhard Auerbach.

Cancer | 1993

Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer

Gabriele Jaques; Bernhard Auerbach; Maria Pritsch; Martin Wolf; Norbert Madry; Klaus Havemann

Background. Small cell lung cancer (SCLC) is distinguished from other histologic types of lung cancer by possessing a variety of neuroendocrine properties. Neuron‐specific enolase (NSE) is the most frequently elevated tumor marker for patients with SCLC at diagnosis. To assess the value of neural cell adhesion molecules (NCAM), another possible tumor marker for small cell lung cancer, NCAM was evaluated in the sera of patients with histologically confirmed SCLC in two prospective multicenter trials.

International Journal of Cancer | 1993

CA 494--a new tumor marker for the diagnosis of pancreatic cancer.

H. Friess; M. Büchler; Bernhard Auerbach; Alexander Weber; P. Malfertheiner; Kai Hammer; Norbert Madry; Sabine Greiner; Klaus Bosslet; Hans G. Beger

Archive | 1995

Use of pairs of leucine zipper peptides in immunoassay methods

Klaus Bosslet; Peter Hermentin; Hans Harald Sedlacek; Bernhard Auerbach; Peter Pfleiderer; Rolf Müller

Archive | 1990

Monoclonal antibodies against tumor associated antigen, their preparation and use

Klaus Bosslet; Gerhard Seemann; Hans-Harald Sedlacek; Bernhard Auerbach

Archive | 1991

Monoclonal antibodies specific for tumor-associated antigens, method for their preparation and their use

Klaus Bosslet; Bernhard Auerbach; Helmut Peters

Archive | 1991

method for the detection of tumour associated antigens

Bernhard Auerbach; Klaus Bosslet; Helmut Peters

Archive | 1994

Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof

Klaus Bosslet; Gerhard Seemann; Hans Harald Sedlacek; Bernhard Auerbach

Archive | 1991

Use of peptide pairs with extremely high mutual specific affinity in the domain of in-vitro diagnostics

Klaus Bosslet; Peter Hermentin; Hans Harald Sedlacek; Bernhard Auerbach; Peter Pfleiderer; Rolf Müller

Archive | 1995

Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof

Klaus Bosslet; Bernhard Auerbach; Helmut Peters

Archive | 1991

Use of pairs of peptides with extremely high specific affinity for one another in the area of in vitro diagnosis

Klaus Bosslet; Peter Hermentin; Hans Harald Sedlacek; Bernhard Auerbach; Peter Pfleiderer; Rolf Müller

Explore More

Collaboration

Dive into the Bernhard Auerbach's collaboration.

Top Co-Authors
Avatar

Klaus Bosslet

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Gerhard Seemann

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Peter Hermentin

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Hans-Harald Sedlacek

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Klaus Bosslet

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Rolf Müller

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Hans Harald Sedlacek

Roussel Uclaf

View shared research outputs
Top Co-Authors
Avatar

Rolf Mueller

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Alexander Weber

University of Ulm

View shared research outputs
Top Co-Authors
Avatar

Franz-Georg Hanisch

University of Cologne

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge